ARTICLE | Company News

QLT, National Eye Institute other research news

June 7, 2004 7:00 AM UTC

QLT entered a CRADA with the National Eye Institute to study the effects of PFTA as an adjunct to Visudyne verteporfin in a Phase III trial in about 300 patients. QLTI will provide funding for the tr...